The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.
about
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The Cochrane Collaboration wit ...... eficit hyperactivity disorder.
@en
The Cochrane Collaboration wit ...... eficit hyperactivity disorder.
@nl
type
label
The Cochrane Collaboration wit ...... eficit hyperactivity disorder.
@en
The Cochrane Collaboration wit ...... eficit hyperactivity disorder.
@nl
prefLabel
The Cochrane Collaboration wit ...... eficit hyperactivity disorder.
@en
The Cochrane Collaboration wit ...... eficit hyperactivity disorder.
@nl
P2093
P2860
P50
P921
P1476
The Cochrane Collaboration wit ...... eficit hyperactivity disorder.
@en
P2093
Juan Erviti
Kim Boesen
Luis Carlos Saiz
Ole Jakob Storebø
P2860
P304
P356
10.1136/EBMED-2017-110716
P577
2017-07-13T00:00:00Z